Previous studies have reported an association of this polymorphism with endothelial dysfunction due to the decreased NOS3 activity in patients with early-onset primary hypertension, diabetes mellitus, and subarachnoid hemorrhage [43,44,45]. This evidence concerns the gene NOS3 and diabetes mellitus.